Hepatitis C-associated keratitis.
Baratz
K H
KH
Fulcher
S F
SF
Bourne
W M
WM
D000998:Antiviral Agents / Q000627:therapeutic use; D015828:Eye Infections, Viral / Q000209:etiology* / Q000473:pathology / Q000628:therapy; D016174:Hepacivirus / Q000235:genetics / Q000276:immunology; D006526:Hepatitis C / Q000150:complications* / Q000473:pathology / Q000628:therapy; D018937:Hepatitis C Antibodies / Q000032:analysis; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000627:therapeutic use; D007634:Keratitis / Q000473:pathology / Q000628:therapy / Q000821:virology*; D008297:Male; D008875:Middle Aged; D016133:Polymerase Chain Reaction; D012367:RNA, Viral / Q000032:analysis; D011994:Recombinant Proteins
D000998:Antiviral Agents; D018937:Hepatitis C Antibodies; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D012367:RNA, Viral; D011994:Recombinant Proteins